Cereblon (CRBN) mediates immunomodulatory drug (IMiD) action in multiple myeloma (MM).
Using 2 different methodologies, we identified 244 CRBN binding proteins and …

FAM46C is one of the most recurrently mutated genes in multiple myeloma; however its role
in disease pathogenesis has not been determined. Here we demonstrate that wild-type (WT) …

Bortezomib is highly effective in the treatment of multiple myeloma; however, emergent drug
resistance is common. Consequently, we employed CRISPR targeting 19,052 human genes …

CLASP2 is a microtubule-associated protein that undergoes insulin-stimulated phosphorylation
and co-localization with reorganized actin and GLUT4 at the plasma membrane. To gain …

We investigated biomarker CEACAM6, a highly abundant cell surface adhesion receptor that
modulates the extracellular matrix (ECM) in pancreatic ductal adenocarcinoma (PDA). The …

The function of insulin receptor substrate-1 (IRS-1) is regulated by both tyrosine and serine/threonine
phosphorylation. Phosphorylation of some serine/threonine residues in IRS-1 …

OBJECTIVE—Research has focused on insulin receptor substrate (IRS)-1 as a locus for insulin
resistance. Tyrosine phosphorylation of IRS-1 initiates insulin signaling, whereas serine/…

Background Immunomodulatory drugs (IMiDs), such as lenalidomide, are therapeutically
active compounds that bind and modulate the E3 ubiquitin ligase substrate recruiter cereblon, …

Insulin receptor substrate 1 (IRS-1), an intracellular substrate of the insulin receptor tyrosine
kinase, also is heavily phosphorylated on serine and threonine residues, and several serine …

Protein–protein interactions are key to most cellular processes. Tandem mass spectrometry (MS/MS)-based
proteomics combined with co-immunoprecipitation (CO-IP) has emerged as …